- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
40 Fatty Liver Trials Near You
Power is an online platform that helps thousands of Fatty Liver patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerPegozafermin for Liver Cirrhosis
Trial Details
Key Eligibility Criteria
762 Participants Needed
Survodutide for Fatty Liver Disease
Trial Details
Key Eligibility Criteria
1590 Participants Needed
Survodutide for Fatty Liver Disease
Trial Details
Key Eligibility Criteria
1800 Participants Needed
Dietary Oils for Fatty Liver Disease
Trial Details
Key Eligibility Criteria
74 Participants Needed
Semaglutide for Non-alcoholic Steatohepatitis
Trial Details
Key Eligibility Criteria
1205 Participants Needed
Miricorilant for Non-Alcoholic Steatohepatitis
Trial Details
Key Eligibility Criteria
195 Participants Needed
NNC0194-0499 + Semaglutide for Fatty Liver Disease
Trial Details
Key Eligibility Criteria
698 Participants Needed
Trial Details
Key Eligibility Criteria
180 Participants Needed
Efruxifermin for NASH
Trial Details
Key Eligibility Criteria
700 Participants Needed
Belapectin for NASH Cirrhosis
Trial Details
Key Eligibility Criteria
357 Participants Needed
Lanifibranor for Nonalcoholic Steatohepatitis (NASH)
Trial Details
Key Eligibility Criteria
1000 Participants Needed
Efruxifermin for NASH
Trial Details
Key Eligibility Criteria
1650 Participants Needed
Resmetirom for Fatty Liver Disease
Trial Details
Key Eligibility Criteria
1759 Participants Needed
DD01 for Fatty Liver Disease
Trial Details
Key Eligibility Criteria
67 Participants Needed
Pegozafermin for Fatty Liver Disease
Trial Details
Key Eligibility Criteria
1050 Participants Needed
K-877-ER + CSG452 for NASH
Trial Details
Key Eligibility Criteria
228 Participants Needed
Survodutide for Obesity and Fatty Liver Disease
Trial Details
Key Eligibility Criteria
218 Participants Needed
Atezolizumab +/− Bevacizumab for Liver Cancer
Trial Details
Key Eligibility Criteria
30 Participants Needed
Efruxifermin for Fatty Liver Disease
Trial Details
Key Eligibility Criteria
1150 Participants Needed
GSK4532990 for NASH
Trial Details
Key Eligibility Criteria
271 Participants Needed
Why Other Patients Applied
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
Efruxifermin for NASH with Cirrhosis
Trial Details
Key Eligibility Criteria
182 Participants Needed
HM15211 for Non-alcoholic Steatohepatitis (NASH)
Trial Details
Key Eligibility Criteria
215 Participants Needed
Efinopegdutide for Nonalcoholic Steatohepatitis (NASH)
Trial Details
Key Eligibility Criteria
360 Participants Needed
Isatuximab for Primary Amyloidosis
Trial Details
Key Eligibility Criteria
43 Participants Needed
Soy Milk for Non-alcoholic Fatty Liver Disease
Trial Details
Key Eligibility Criteria
44 Participants Needed
AZD2693 for Non-alcoholic Steatohepatitis with Fibrosis
Trial Details
Key Eligibility Criteria
220 Participants Needed
HTD1801 for Non-alcoholic Fatty Liver Disease
Trial Details
Key Eligibility Criteria
218 Participants Needed
Metabolic Surgery for Non-Alcoholic Fatty Liver Disease
Trial Details
Key Eligibility Criteria
120 Participants Needed
Milk Thistle for Pediatric Fatty Liver Disease
Trial Details
Key Eligibility Criteria
20 Participants Needed
Vitamin E for Non-alcoholic Fatty Liver Disease
Trial Details
Key Eligibility Criteria
200 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Fatty Liver clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Fatty Liver clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Fatty Liver trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Fatty Liver is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Fatty Liver medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Fatty Liver clinical trials?
Most recently, we added Milk Thistle for Pediatric Fatty Liver Disease, Survodutide for Fatty Liver Disease and SMOFlipid for Malnutrition to the Power online platform.